Published in Gene Therapy Weekly, February 16th, 2006
"Ovarian cancer represents the fifth leading cause of cancer death among women in the United States, with 416,000 deaths expected this year. This study was carried out to investigate the potential of NIS-mediated radioiodide therapy as a novel approach for ovarian cancer treatment," wrote R.M. Dwyer and colleagues, Department of Endocrinology & Internal Medicine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.